Takeshi Nagasaka

Professor / Director

Kawasaki Medical School

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Takeshi Nagasaka currently serves as the Director at Kawasaki Medical School in Japan. His research focuses on pain mechanisms, colorectal cancer biomarkers, and treatment efficacy, with recent publications exploring various aspects of gastric and colorectal cancers. His work includes studies on microRNA, cell-free DNA methylation patterns, and novel treatment protocols in oncology.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Shigeru MITANI

Professor

Kawasaki Medical School

JAPAN

View details

Toshiyoshi Fujiwara

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takeshi Nagasaka

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Circulating microRNAs differentiate nociceptive and nociplastic pain: An exploratory study.

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade

Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer

Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study

Technique of vessel-skeletonized parenchyma-sparing hepatectomy for the oncological treatment of bilobar colorectal liver metastases

A Trial Protocol of Precision Medicine for Patients with RAS Wild Metastatic Colorectal Cancer Using Liquid Biopsy (RAS-liquid Study): A Prospective, Multicenter Observational Study

Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations

[Corrigendum] Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study

Collaborators (2)

Shigeru MITANI

Toshiyoshi Fujiwara

Make your next move.